Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
15.59
-0.13 (-0.83%)
At close: Feb 20, 2026, 4:00 PM EST
15.63
+0.04 (0.24%)
After-hours: Feb 20, 2026, 4:10 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Development and Commercialization of Vascepa | 228.61M | 306.91M | 369.19M | 583.19M | 614.06M | | | | | |
Development and Commercialization of Vascepa Growth | -25.51% | -16.87% | -36.69% | -5.03% | 42.89% | | | | | |
| 228.61M | 306.91M | 369.19M | 583.19M | 614.06M | | | | | |
| -25.51% | -16.87% | -36.69% | -5.03% | 42.89% | | | | | |
Source: S&P Global Market Intelligence.
